Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm
Immunology
[키워드] “cytokine storm”
activate
acute respiratory syndrome
affected
Anti-inflammatory
approach
approved
cause
caused
characterized
China
Cholinergic anti-inflammatory pathway
clinically
COVID- 19
COVID-19
CRS
Cytokine Release Syndrom (CRS)
Cytokine release syndrome
effort
epidemiological
Evidence
Hospitalized
hyperinflammation
Hypothesis
Inflammation
inhibit
less
lung
many cases
New coronavirus
Nicotine
pathway
patients
pro-inflammatory cytokine
Proinflammatory cytokine
receptor
reduce
Release
rising mortality
Safe
SARS-CoV-2
SARS-CoV-2 (virus)
severe SARS-CoV-2
Signal transduction
smoker
statistically
storm
Therapies
therapy
Treatment
ulcerative colitis
worldwide pandemic
[DOI] 10.3389/fimmu.2020.01359 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2020.01359 PMC 바로가기 [Article Type] Immunology